Wells Fargo’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Wells Fargo’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,245	Closed	-$6.29K	–	7814
2023 Q4	$6.29K	Buy	5,245 +1,222	+30%	+$1.32K	﹤0.01%	5926
2023 Q3	$3.47K	Sell	4,023 -2,607	-39%	-$2.86K	﹤0.01%	6007
2023 Q2	$7.96K	Buy	6,630 +6,519	+5,873%	+$32.6K	﹤0.01%	5960
2023 Q1	$970	Buy	111 +42	+61%	+$388	﹤0.01%	6392
2022 Q4	$552	Buy	69 +1	+1%	+$6	﹤0.01%	6362
2022 Q3	$0	Sell	68 -982	-94%	-$6.17K	﹤0.01%	7656
2022 Q2	$6K	Sell	1,050 -639	-38%	-$2.19K	﹤0.01%	5966
2022 Q1	$9K	Sell	1,689 -5,916	-78%	-$47.4K	﹤0.01%	6327
2021 Q4	$98K	Buy	+7,605	New	+$109K	﹤0.01%	5653

Wells Fargo's RAIN Position: Q1 2024 in Review

Wells Fargo sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 5,245 shares — an estimated $6.29K sold.

Wells Fargo first reported a position in RAIN in Q4 2021 and held it in 9 quarters. The position peaked at $98K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Wells Fargo reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Wells Fargo sold 5,245 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $6.29K.
Wells Fargo first reported a position in Rain Oncology Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Wells Fargo's Rain Oncology Inc. Common Stock position peaked at $98K in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.